Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
Huber V, Di Guardo L, Lalli L, Giardiello D, Cova A, Squarcina P, Frati P, Di Giacomo AM, Pilla L, Tazzari M, Camisaschi C, Arienti F, Castelli C, Rodolfo M, Beretta V, Di Nicola M, Maio M, Del Vecchio M, de Braud F, Mariani L, Rivoltini L.
Huber V, et al. Among authors: camisaschi c.
J Immunother Cancer. 2021 Feb;9(2):e001167. doi: 10.1136/jitc-2020-001167.
J Immunother Cancer. 2021.
PMID: 33589521
Free PMC article.